Clinical outcomes of splenorenal shunts in esophageal varices patients: a literature review
Main Article Content
Keywords
esophageal varices, outcome, splenorenal shunt
Abstract
The disease known as esophageal varices is usually caused by portal hypertension. Portal hypertension is most commonly caused by extrahepatic portal vein thrombosis and other conditions, such as cardiac problems or hepatic cirrhosis. Clinical manifestations of esophageal varices can include melena, haematemesis, and gastrointestinal bleeding. Effective venous pressure reduction is achieved via the distal splenorenal shunt. We acquired the literature for our review from PubMed and Google Scholar. The search was done in English using terms that indicated a connection between improvements in bone grafting methods and the restoration of alveolar clefts. To expand the search results, we also looked through the papers cited in the literature. Almost all of the five gathered articles demonstrated that the distal splenorenal shunt (DSRS) is a beneficial surgical treatment that effectively avoids postoperative PH issues. Finally, DSRS is presented as a surgical long-term treatment for variceal esophageal reflux disease and portal hypertension. Because DSRS selectively decompresses the venous collaterals around the stomach and lower esophagus, it is a safe and effective therapy choice for decreasing bleeding over nonselective shunting surgeries as a selective shunt.
References
2. Tandon P, Bishay K, Fisher S, Yelle D, Carrigan I, Wooller K, et al. Comparison of clinical outcomes between variceal and non-variceal gastrointestinal bleeding in patients with cirrhosis. J Gastroenterol Hepatol. 2018 Oct;33(10):1773–9.
3. Nery F, Correia S, Macedo C, Gandara J, Lopes V, Valadares D, et al. Nonselective beta-blockers and the risk of portal vein thrombosis in patients with cirrhosis: results of a prospective longitudinal study. Aliment Pharmacol Ther. 2019 Mar;49(5):582–8.
4. Marti J, Gunasekaran G, Iyer K, Schwartz M. Surgical management of noncirrhotic portal hypertension. Clin Liver Dis. 2015;5(5):112–5.
5. Wu X, Xuan W, Song L. Transjugular intrahepatic portosystemic stent shunt placement and embolization for hemorrhage associated with rupture of anorectal varices. J Int Med Res. 2018;46(4):1666–71.
6. Henderson JM. Distal splenorenal shunt. Atlas Up Gastrointest Hepato-Pancreato-Biliary Surg. 2007;141:653–63.
7. Van Praet KM, Ceulemans LJ, Monbaliu D, Aerts R, Jochmans I, Pirenne J. An analysis on the use of Warren’s distal splenorenal shunt surgery for the treatment of portal hypertension at the University Hospitals Leuven. Acta Chir Belg [Internet]. 2021;121(4):254–60. Available from: https://doi.org/10.1080/00015458.2020.1726099
8. Al-Saeedi M, Frank-Moldzio L, Contin P, Mayer P, Loos M, Schmidt T, et al. Splenorenal shunt for reconstruction of the gastric and splenic venous drainage during pancreatoduodenectomy with resection of the portal venous confluence. Langenbeck’s Arch Surg [Internet]. 2021;406(7):2535–43. Available from: https://doi.org/10.1007/s00423-021-02318-2
9. Nordmann T, Schlabe S, Feldtid T, Gobbi F, Krieg A, Bode JG, et al. TIPS and splenorenal shunt for complications of portal hypertension in chronic hepatosplenic schistosomiasis–A case series and review of the literature. PLoS Negl Trop Dis [Internet]. 2021;15(12):1–15. Available from: http://dx.doi.org/10.1371/journal.pntd.0010065
10. Zhang JS, Cheng W, Li L. Laparoscopic distal splenoadrenal shunt for the treatment of portal hypertension in children with congenital hepatic fibrosis: A case report. Med (United States). 2017;96(3):2–6.
11. Rehman ZU, Nazir Z. Distal splenorenal shunt (DSRs) in children with extrahepatic portal hypertension. J Coll Physicians Surg Pakistan. 2019;29(12):1228–9.
12. Livingstone AS, Koniaris LG, Perez EA, Alvarez N, Levi JU, Hutson DG. 507 Warren-Zeppa distal splenorenal shunts: a 34-year experience. Ann Surg. 2006 Jun;243(6):884.
13. Busuttil RW, Maywood BT, Tompkins RK. The Warren shunt in treating bleeding esophageal varices. West J Med. 1979;130(4):304–8.
14. Spina G, Santambrogio R, Opocher E, Galeotti F, Cucchiaro G, Strinna M, et al. Improved quality of life after distal splenorenal shunt. A prospective comparison with side-to-side portacaval shunt. Ann Surg. 1988;208(1):104–9.
15. Gandras E, Chen K, Goldstein G, Madariaga J, Krishnasastry K, Greben C. Endovascular Salvage of Early Distal Splenorenal Shunt Occlusion With Resultant Long-term Patency. J Vasc Surg. 2017;65(6):123S-124S.
16. Elwood DR, Pomposelli JJ, Pomfret EA. Distal Splenorenal Shunt Preferred Treatment for Recurrent Variceal Hemorrhage in the Patient With Well-Compensated Cirrhosis. JAMA Surg. 2006;141(4):385–8.
17. Rodge GA, Goenka U, Goenka MK. Management of Refractory Variceal Bleed in Cirrhosis. J Clin Exp Hepatol [Internet]. 2022;12(2):595–602. Available from: https://doi.org/10.1016/j.jceh.2021.08.030
18. Nigatu A, Yap JE, Lee Chuy K, Go B, Doukky R. Bleeding Risk of Transesophageal Echocardiography in Patients With Esophageal Varices. Vol. 32, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. United States; 2019. p. 674-676.e2.
19. Ozdogan E, Arikan C. Liver fibrosis in children: a comprehensive review of mechanisms, diagnosis, and therapy. Clin Exp Pediatr. 2023;66(3):110–24.